drugset / Trial / NCT02078609
A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will assess the safety and preliminary efficacy of escalating doses of LGH447 monotherapy in AML and MDS and LGH447 in combination with midostaurin in AML.
Timeline
- Start
- 2014-03-20
- Primary completion
- 2019-04-18
- Completion
- 2019-04-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LGH447 | Small molecule | — | Oral |
| Background | Midostaurin | Small molecule | — | — |